• ABOUT NEWBRIDGE

    Our Business Network and Unique Value Proposition Provide a Platform to Bridge the Access Gap of Global Innovation Within MENA Region

     

  • 1

Region

The MENA Region has drawn a lot of interest in the pharmaceutical industry in recent years, principally due to huge investment in both the private and public sectors; the introduction of mass health insurance and several moves to liberalize national economies. Egypt, Saudi Arabia, Algeria, Jordan, U.A.E, Lebanon and Kuwait are some of the major markets in the Region.

The MENA region will remain one of the fastest growing regions in the world over the next few years due to:

  1. Significant government spending on infrastructure
  2. A very young and fast-growing population
  3. Increasing flow of private investment as more of these emerging markets open 
  4. Increasing access to innovative new medicines due to the rise in chronic diseases and increased coverage of health insurance 

The Region includes a mix of  relatively wealthy but not-yet-saturated markets, fast-growing emerging markets, and a number of under developed markets which together result in long term growth prospects within the Region.

NewBridge utilizes its regional network to partner with companies to seize the opportunity of entering the fastest-growing markets in the Region, whilst helping to balance the risk that is often associated with doing business in new territories.

 

Country2015 Est. Pop2015 GDP per Capita (in USD)2014 HC expenditure/capita (in USD)
Algeria39,666,519$4,206.0362
Bahrain1,377,237$22,600.21243
Egypt91,508,084$3,614.7178
Iraq36,423,395$4,943.8292
Jordan7,594,547$4,940.0359
Kuwait3,892,115$29,300.61386
Lebanon6,184,701$8,047.6569
Morocco34,377,511$2,878.2190
Oman4,490,541$15,550.7675
Qatar2,235,355$73,653.42106
Saudi Arabia31,540,372$20,481.71147
Tunisia11,107,800$3,872.5305
UAE9,156,963$40,438.81611

Sources:
1.  www.worldbank.org